Aktive Positionen von Ioana C. Hone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Investor Relations Kontakt | - | - |
Karriereverlauf von Ioana C. Hone
Ehemalige bekannte Positionen von Ioana C. Hone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LIFEVANTAGE CORPORATION | Public Communications Contact | 21.09.2010 | - |
| SAVARA INC. | Investor Relations Kontakt | - | - |
| Public Communications Contact | - | - | |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Investor Relations Kontakt | 12.04.2011 | - |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
Sektoral
| Health Technology | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| LIFEVANTAGE CORPORATION | Health Technology |
| SAVARA INC. | Health Technology |
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Ioana C. Hone
- Erfahrung
